EUA
cobas SARS-CoV-2 Duo for use on the cobas 6800/8800 Systems
FDA Emergency Use Authorization · Roche Molecular Systems, Inc. · Jun 14, 2022
Key facts
| Product | cobas SARS-CoV-2 Duo for use on the cobas 6800/8800 Systems |
|---|---|
| Company | Roche Molecular Systems, Inc. |
| Product type | Real-time RT-PCR, Quantitative, Multiple Targets |
| Date | Jun 14, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: